Google, Novartis Partner To Revolutionize Healthcare – ValueWalk Premium

Google, Novartis Partner To Revolutionize Healthcare

Google Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Swiss drugmaker Novartis AG (ADR) (NYSE:NVS) (VTX:NOVN) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co. Ltd. (LON:BC94) (KRX:0059935) in the race to control consumers healthcare applications.

The product under joint development is “smart” contact lenses that track blood glucose levels or restore the . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0